Orthofix Medical
OFIX
156 hedge funds and large institutions have $511M invested in Orthofix Medical in 2023 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 43 increasing their positions, 54 reducing their positions, and 48 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
16% more capital invested
Capital invested by funds: $439M → $511M (+$72M)
10.16% more ownership
Funds ownership: 93.01% → 103.17% (+10%)
4% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 48
2% less funds holding
Funds holding: 159 → 156 (-3)
20% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 54
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$44M |
| 2 |
ECM
Engine Capital Management
New York
|
+$35.7M |
| 3 |
NM
Newtyn Management
New York
|
+$12.4M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.59M |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$7.59M |
Top Sellers
| 1 |
BlackRock
New York
|
-$31.1M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$23.8M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$15.3M |
| 4 |
SCM
Sio Capital Management
New York
|
-$8.36M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.71M |
OFIX Hedge Fund Activity: Q4 2023 in Review
156 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q4 2023, worth a combined $511M — up 16% from $439M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of OFIX and 46 opened new positions — a net loss of 2 holders — while 54 trimmed existing stakes and 43 added.
The largest buyer was Morgan Stanley, adding an estimated $44M. The largest seller was BlackRock, cutting an estimated $31.1M.
- 156 institutional investors held Orthofix Medical (OFIX) as of Q4 2023, down from 159 in Q3 2023.
- Funds reported $511M of Orthofix Medical stock for Q4 2023, up 16% quarter-over-quarter.
- 46 funds opened new Orthofix Medical positions in Q4 2023 and 48 closed out, a net change of -2 holders.
- The largest Orthofix Medical buyer in Q4 2023 was Morgan Stanley, an estimated $44M added.
- The largest Orthofix Medical seller in Q4 2023 was BlackRock, an estimated $31.1M sold.
Based on aggregated 13F filings for Q4 2023.